Pharmaceutical Price Controls and Entry Strategies
- 1 February 2007
- journal article
- Published by MIT Press in The Review of Economics and Statistics
- Vol. 89 (1), 88-99
- https://doi.org/10.1162/rest.89.1.88
Abstract
This paper finds that the use of price controls has a statistically and quantitatively important effect on the extent and timing of the launch of new drugs. Firms headquartered in countries that regulate price reach fewer markets than those in countries without price controls. Companies avoid price-controlled markets, and are less likely to introduce products in additional markets after entering a price-controlled country. Launches into low-price European countries are further delayed following legalization of parallel imports. The results suggest that price regulation in one country affects entry into other countries, and may affect the strategies of domestic firms. Copyright by the President and Fellows of Harvard College and the Massachusetts Institute of Technology.Keywords
This publication has 15 references indexed in Scilit:
- The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990sHealth Economics, 2004
- Market Size in Innovation: Theory and Evidence from the Pharmaceutical IndustryThe Quarterly Journal of Economics, 2004
- Static and Dynamic Effects of Health Policy: Evidence from the Vaccine IndustryThe Quarterly Journal of Economics, 2004
- Groups, the Media, Agency Waiting Costs, and FDA Drug ApprovalAmerican Journal of Political Science, 2002
- The Regulation of EntryThe Quarterly Journal of Economics, 2002
- Does Regulation Drive Out Competition in Pharmaceutical Markets?The Journal of Law and Economics, 2000
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Characteristics of demand for pharmaceutical products: an examination of four cephalosporins.The RAND Journal of Economics, 1997
- Do Important Drugs Reach the Market Sooner?The RAND Journal of Economics, 1994
- Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical IndustryBrookings Papers on Economic Activity. Microeconomics, 1991